stars 1 stars 2 stars 3

INOVIQ Ltd (ASX:IIQ) is a biotechnology company developing next-generation diagnostics and therapeutics for cancer. INOVIQ has commercialised its fast, efficient and scalable EXO-NET exosome isolation technology for biomarker discovery and diagnostics development, and the hTERT test as an adjunct test for bladder cancer. The company is advancing clinical-stage diagnostics for detection and monitoring of ovarian and breast cancers, and early-stage exosome therapeutics for solid tumours.

BARD1 Life Sciences Ltd Questions

The BARD1 Life Sciences Ltd annual revenue was $6 million in 2026.

Leearne Hinch is the CEO of BARD1 Life Sciences Ltd.

18 people are employed at BARD1 Life Sciences Ltd.

BARD1 Life Sciences Ltd is based in Notting Hill, Victoria.

The NAICS codes for BARD1 Life Sciences Ltd are [325, 3254, 32541, 325413, 32].

The SIC codes for BARD1 Life Sciences Ltd are [28, 283].

Top BARD1 Life Sciences Ltd Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users